This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Thursday, June 30, 2011
Metformin; Preventing diabetes in at-risk patients
SAN DIEGO -- Starting patients on metformin and lifestyle interventions are both cost-effective means of preventing diabetes in at-risk patients, researchers said here.
No comments:
Post a Comment